EMU-116

Avis client

Based on 1 Customer Validation

EMU-116 is an orally active CXCR4 antagonist. EMU-116 blocks the CXCL12-CXCR4 signaling axis by competitively binding to the CXCR4 receptor, thereby achieving broad mobilization of bone marrow stem/progenitor cells and immune cells into peripheral blood while simultaneously inhibiting tumor metastasis and microenvironmental immunosuppression. EMU-116 can be used for research on cancer, chemotherapy-induced neutropenia, and sickle cell disease.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté : 98.53%
  • CAS No.: 2241724-59-2
  • Formule: C25H35N5
  • Masse moléculaire:405.58
  • Stockage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Activité biologique
  • Chemical Information
  • Solvant et solubilité
  • Protocole
  • Pureté et documentation
  • Références
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00